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stable angina were included. Inclusion criteria – coronary bifurcation
lesions, RVD  2.5 – 4.5 mm; SB RVD  2.0 mm. Exclusion criteria:
STEMI; LM stenosis; CTOs; lesion of interest located at infarct-related
artery; LVEF < 30%; moderate/severe degree valvular disease; pri-
mary cardiomyopathy; L/RBBB, atrial ﬁbrillation/ﬂutter with no
identiﬁable isoelectric line. Intracoronary ECG was recorded by con-
necting outer end of PCI guidewire with V-unipolar lead of ECG. The
BARI risk score was calculated according to length of the vessels
beyond the lesion divided to total vessel length. Troponin concen-
tration difference (Tn postPCI – Tn prePCI) was divided to BARI
bifurcation lesion score (TnD/BARI).
RESULTS Absolute Tn concentration after PCI increased linearly with
the increase of ischemic zone (residual ischemia presented in SB re-
gion only, MB region only or both on icECG – see ﬁgure). However,
when normalized, there was a signiﬁcant difference in necrosis
amount when ischemic territory increased (SBþMB > MB >>> SB,
p¼.029). At 1-year follow-up, using cut-off of 0.001 of TnD/BARI, there
was a signiﬁcant difference in TLR rates in groups with increased TnD/
BARI ratio – 3/14 (21%) vs. 1/55 (2%), p¼.007, as well as MACEs – 6/14
(43%) vs. 9/55 (16%), p¼.005.
CONCLUSIONS The normalized ratio of Troponin difference to area at
risk for myonecrosis after PCI of coronary bifurcation lesions is asso-
ciated with the amount of residual ischemia at end of procedure and
discriminates patients with increased risk of future adverse events.
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BACKGROUND Recent data from ﬁve-year results of SYNTAX trial
showed superiority of Coronary Artery Bypass Graft (CABG) with
regards to all major outcomes (mortality, MI, MACCE, repeat revas-
cularization) whereas stroke rate was similar to Percutaneous Coro-
nary Revascularization (PCI). We sought to compare ﬁve-year
outcomes of PCI Vs CABG.
METHODS PubMed & Web of Science were searched for English lan-
guage studies up to 1st June 2015 comparing ﬁve-year outcomes of PCI
Vs CABG. Study quality, publication bias & heterogeneity were
assessed. Meta-analysis was performed using DerSimonian-Liard
random effects method. Outcomes were reported for following
groups: PCI Vs CABG, PCI with drug eluting stents (DES) Vs CABG, PCI
Vs CABG in diabetes and PCI with DES Vs CABG in diabetes.
RESULTS 10 studies were identiﬁed (n: PCI 6157 CABG 6029). Age (PCI
66 yrs CABG 64.9 yrs) and gender distribution (Males: PCI 73.4% CABG
77%) were similar. Overall, PCI was associated with worse MAC-
CE(RR 1.53, CI 1.40-1.68, p<0.001), MI(RR 1.48, CI 1.05-2.09, p¼0.02) &
repeat revascularization rates(RR 2.70, CI 2.06-3.55, p<0.001) while
all-cause mortality(RR 1.05, CI 0.90-1.23, p¼0.51), cardiac mortal-
ity(RR 1.20, CI 0.98-1.46, p¼0.07) were similar. Stroke (RR 0.79, CI
0.66-0.95, p¼0.01) was lower with PCI. Use of DES for PCI did not alter
these outcomes while stroke (RR 0.64, CI 0.49-0.85, p¼0.002)
remained higher with CABG. In diabetics, PCI was associated withworse outcomes [all-cause mortality (RR 1.35, CI 1.17-1.56, p<0.001),
cardiac mortality (RR 1.36, CI 1.12-1.66, p¼0.002), MI(RR 2.31, CI 1.79-
2.97, p<0.001), MACCE(RR 1.74, CI 1.45-2.00, p<0.001), repeat
revascularization(RR 3.37, CI 2.96-3.84, p<0.001)] while stro-
ke(RR 0.78, CI 0.53-1.14, p¼0.20) was similar to CABG . Use of DES in
diabetics yielded similar results except for the stroke (RR 0.59, CI
0.42-0.84, p¼0.003) that was higher with CABG.
CONCLUSIONS In unselected patients PCI was associated with worse
outcomes in terms of higher MACCE, MI, revascularization though
stroke favored PCI regardless of the type of stent used. In diabetics
our meta-analysis ﬁndings agreed with SYNTAX trial results favoring
CABG for all major outcomes with similar stroke rate as PCI.
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BACKGROUND Modern randomized controlled trials typically use
composite endpoints. This is only valid if each endpoint is equally
important to patients but few trials document patient preference and
seek the relative importance of components of combined endpoints. If
patients weigh endpoints differentially, our interpretation of trial data
needs to be reﬁned.
METHODS We derive a quantitative, structured tool to determine
the relative importance of each endpoint to patients. We then apply
this tool to data comparing angioplasty with drug-eluting stents to
bypass surgery. The survey was administered to patients undergoing
cardiac catheterization. A meta-analysis comparing CABG to PCI was
then performed using (a) standard MACE and (b) patient-centered
MACE.
RESULTS Patients considered stroke worse than death (stroke
102.319.6%, p<0.01), and MI and repeat revascularization less severe
than death (61.926.8% and 41.9  25.4% respectively p<0.01 for
both). 7 RCTs (5251 patients) were eligible. Meta-analysis demon-
strated that standard MACE occurs more frequently with PCI than
surgery (OR 1.44; 95% CI 1.10 to 1.87; p¼0.007). Re-analysis using
patient-centered MACE found no signiﬁcant difference between PCI
and CABG (OR 1.22, 95% CI 0.97 to 1.53; p¼0.10).
CONCLUSIONS Patients do not consider the constituent endpoints of
MACE equal. We derive a novel patient-centered metric that recog-
nizes and quantiﬁes the differences attributed to each endpoint.
When patient preference data are applied to contemporary trial re-
sults, there is no signiﬁcant difference between PCI and CABG. Re-
sponses from individual patients in clinic could be used to give
individual patients a recommendation that is truly personalized.
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BACKGROUND Patients with diabetes and multivessel coronary ar-
tery disease treated with multivessel percutaneous coronary inter-
vention (MVPCI) have higher mortality, non-fatal myocardial
infarction and repeat revascularization rates compared to coronary
artery bypass graft surgery (CABG). Our study objective is to assess the
trend of MVPCI with stent placement in diabetic patients.
METHODS Data were obtained from nationwide inpatient sample
from 2006-2012, which is a 20% stratiﬁed probability sample of dis-
charges in all community hospitals participating in Healthcare Cost
and Utilization Project. International Classiﬁcation of Diseases 9 codes
were used to identify diabetic patients who underwent percutaneous
coronary intervention with stents in two or more vessels. Patients
who had history of CABG, cardiac transplant, missing data, or
were <18 years old were excluded. Trend analysis was performed on
the number of MVPCIs.
RESULTS A total of 41,586 patients underwent MVPCI between 2006
and 2012. The mean age of the patients undergoing MVPCI was
65.211.46 years. There were 59.89% males and 40.11% females. The
trend analysis showed that incidence of MVPCI in diabetics decreased
by 40.49% from a peak of 8179 in 2006 to 4867 in 2012 (Figure). Drug
eluting stents were used in 78% patients, while non-drug eluting
stents were used in 15.4% patients, and 6.6% of the patients received
both.CONCLUSIONS There was a signiﬁcant decrease in the number of
MVPCI procedures performed on diabetic patients with multivessel
coronary artery disease between year 2006 and 2012.
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BACKGROUND Unprotected left main coronary artery (ULMCA)
stenting has been performed as an alternative to coronary artery
bypass grafting (CABG). However, beneﬁts of percutaneous coronary
intervention (PCI) in patients with ULMCA disease and reduced left
ventricular ejection fraction (LVEF) have not been established.
METHODS We identiﬁed 364 patients with left ventricular systolic
dysfunction (LVEF less than 45%) who underwent left main coronary
revascularization by PCI and CABG from IRIS-MAIN registry (total 4253
patients) between February 2003 and June 2014. The primary end point
was a major adverse cardiac or cerebrovascular event (MACCE), which
was composite of all cause of death,myocardial infarction, target vessel
revascularization or cerebrovascular event, were compared between
those undergoing PCI (n¼137) and CABG (n¼227) at 1 year follow-up.
RESULTS Mean age was 66.711.6 years and 65.08.8 years in the PCI
and CABG groups, respectively (p¼0.17). Male made up 77% and 81%
(p¼0.37). The 1-year incidence of MACCE was similar between two
groups (PCI: 18.8% vs. CABG: 13.0%, p¼0.16). In addition, death (11.9%
vs. 9.8%, p¼0.30), MI (0.9% vs. 0.5%, p¼0.68) and target vessel
revascularization was not signiﬁcantly different (PCI: 5.2% vs. CABG:
1.9%, p¼0.13). After adjustment, the hazard ratio was 1.40 (95% con-
ﬁdence interval [CI]: 0.71 – 2.79, p¼0.33); for all cause of death; 2.37
(95% CI: 0.64 – 8.75, p¼0.20) for target vessel revascularization; 1.49
(95% CI: 0.85 – 2.62, p¼0.16) for MACCE.
Table 1. Incidence of Clinical Outcomes at 1 YearClinical Outcomes PCI (N[137) CABG (N[227) P valueMACCEy 25 (18.8%) 29 (13.0%) 0.160
Death 18 (11.9%) 22 (9.8%) 0.301Cardiac death 11 (8.3%) 14 (9.3%) 0.204Myocardial Infarction 1 (0.9%) 1 (0.5%) 0.678Any Repeat Revascularization 7 (5.1%) 5 (2.2%) 0.145Target Vessel Revascularization 6 (4.3%) 4 (1.9%) 0.127Cerebrovascular event 2 (1.5%) 4 (1.9%) 0.846yThe composite of all cause of death, myocardial infarction, target vessel revascularization and cerebro-
vascular event
